SynthesisNeurosurgical review2025
Utility of Bone Cement for Cranioplasty Following Retrosigmoid or Translabyrinthine Craniectomy: A Systematic Review and Meta-Analysis.
Synthesis in Neurosurgical review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesTranslabyrinthine and retrosigmoid craniectomies carry high risk of wound complications. The goal of this study was to compare the effectiveness of bone cement versus no bone cement for translabyrinthine and retrosigmoid craniectomies in reducing the odds of cerebrospinal fluid (CSF) leaks, pseudomeningoceles, Surgical Site Infections (SSIs), and meningitis. MATERIALS AND
methodsA systematic review of the literature in databases was conducted for all relevant literature. Studies comparing outcomes of bone cement versus no bone cement use in adults undergoing retrosigmoid or translabyrinthine craniectomies were included. Bone cement group involved use of methylmethacrylate, calcium phosphate, or hydroxyapatite and non-bone cement - autologous bone, titanium mesh cranioplasty, or fat graft alone. Supratentorial or midline suboccipital craniectomies were excluded. Odds ratios (ORs) for outcomes with 95% confidence intervals (CIs) were calculated using the random-effects model.
resultsFrom a total of 347 titles identified, 8 studies were chosen for analysis. There were a total of 1,044 and 1,021 patients in the cement and non-cement groups, respectively. In the retrosigmoid craniectomy cohort, bone cement was associated with lower odds of CSF leak (OR: 0.25 [CI: 0.14, 0.43], p<0.0001), pseudomeningocele (OR: 0.25 [CI: 0.14, 0.45], p<0.0001), SSI (OR: 0.27 [CI: 0.08, 0.98], p=0.05), and meningitis (OR: 0.13 [CI: 0.04, 0.45], p=0.001). There were no statistically significant differences in the translabyrinthine cohort.
conclusionsBone cement cranioplasty reduced the odds of CSF leaks, pseudomeningoceles, SSIs, and meningitis for retrosigmoid craniectomies and had equivalent outcomes for translabyrinthine craniectomies. This systematic review was based on retrospective cohort studies.
Indexed as
Identifiers
41254416What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.